Caricamento...
Pathological response of salivary duct carcinoma to trastuzumab and docetaxel therapy
Salivary duct carcinoma (SDC) has a poor prognosis owing to the high incidence of distant metastasis. Approximately 40 % of SDCs are positive for human epidermal growth factor receptor 2 (HER2), suggesting that anti-HER2 therapy for cases with distant metastasis may be effective. However, the pathol...
Salvato in:
| Pubblicato in: | Int Cancer Conf J |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Japan
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498293/ https://ncbi.nlm.nih.gov/pubmed/31149444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-016-0247-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|